Atlas Trials

A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils

Clinical trial NCT02693769 · TERMINATED

Trial details

NCT number
NCT02693769
Sponsor
Mundipharma Research Limited
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
ACOS (Fixed Airflow Obstruction and Elevated Eosinophils)
Start date
2016-07-01
Primary completion
2016-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.